Cited by 2,266Long-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients

Open access
Li, Yan‐Chao, Bai, Wan‐Zhu, Hashikawa, Tsutomu·2020·Journal of Medical Virology

Abstract

Following the severe acute respiratory syndrome coronavirus (SARS‐CoV) and Middle East respiratory syndrome coronavirus (MERS‐CoV), another highly pathogenic coronavirus named SARS‐CoV‐2 (previously known as 2019‐nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS‐CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID‐19) with clinical symptoms similar to those reported for SARS‐CoV and MERS‐CoV. The most characteristic symptom of patients with COVID‐19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID‐19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS‐CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse‐connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS‐CoV and SARS‐CoV2, it remains to make clear whether the potential invasion of SARS‐CoV2 is partially responsible for the acute respiratory failure of patients with COVID‐19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS‐CoV‐2‐induced respiratory failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jmv.25728

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence of CNS invasion through neuronal retrograde routes was reported for coronaviruses HCoV-OC43, HEV67 and avian bronchitis virus.

    “Evidence of CNS invasion through neuronal retrograde routes was reported for coronaviruses, such as HCoV-OC43, HEV67 and avian bronchitis virus [32].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, Y., Bai, W., & Hashikawa, T.
Affiliations
  • Department of Histology and Embryology, College of Basic Medical Sciences, Norman Bethune College of Medicine Jilin University Changchun Jilin China
  • Institute of Acupuncture and Moxibustion China Academy of Chinese Medical Science Beijing China
  • RIKEN (JP)
Venue
Journal of Medical Virology
Publisher
Wiley
Published
2020-03-11
Volume
92
Issue
6
Pages
552-555
ISSN
  • 0146-6615 (ISSN-L)
  • 1096-9071
OpenAlex
W3007201727
Cited by
2,266
References
54
Citations by year
2026: 10 · 2025: 38 · 2024: 84 · 2023: 150 · 2022: 315 · 2021: 633 · 2020: 1033 · 2019: 1
FWCI
59.82
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, neuroinvasion, central nervous system infection, acute respiratory failure, neurological symptoms, brainstem infection, respiratory distress, intensive care
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Central Nervous System, China, Headache, Humans, Lung, Nausea, Pneumonia, Viral, Respiratory Insufficiency, Vomiting, Coronavirus Infections, Mechanotransduction, Cellular, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review